NCT00909103

Brief Summary

The aim of the study is to assess elastography during EUS examinations of focal pancreatic masses, and to consequently differentiate benign versus malignant pancreatic masses in a prospective multi-center design.

Trial Health

98
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
285

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2008

Geographic Reach
10 countries

18 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2008

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

May 25, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 27, 2009

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2009

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2009

Completed
Last Updated

January 12, 2010

Status Verified

January 1, 2010

Enrollment Period

1.4 years

First QC Date

May 25, 2009

Last Update Submit

January 11, 2010

Conditions

Keywords

Endoscopic Ultrasound ElastographyPancreatic adenocarcinomaChronic Pancreatitis

Outcome Measures

Primary Outcomes (1)

  • Value of endoscopic ultrasound elastography for the differential diagnoses of pancreatic masses.

    18 months

Study Arms (2)

Pancreatic adenocarcinoma

Patients diagnosed with solid pancreatic adenocarcinoma masses, with cytological / histological confirmation

Chronic pancreatitis

Patients diagnosed with solid pancreatic tumor masses with all the criteria fulfilled to exclude pancreatic cancer

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The diagnosis of chronic pancreatitis will be based on the clinical information (history of alcohol abuse, previous diagnosis of chronic pancreatitis or diabetes mellitus), as well as a combination of imaging methods (ultrasound, CT and EUS). At least four criteria of chronic pancreatitis during EUS will be considered for the positive diagnosis. A positive cytological diagnosis will be taken as a final proof of malignancy of the pancreas mass. The diagnoses obtained by EUS-FNA will be further verified either by surgery or during a clinical follow-up of at least 6 months.

You may qualify if:

  • Patients diagnosed with solid pancreatic tumor masses, with cytological / histological confirmation
  • Age 18 to 80 years old, men or women
  • Signed informed consent for EUS with elastography and FNA biopsy

You may not qualify if:

  • Prior surgical treatment with curative intent or chemo-radiotherapy
  • Patients diagnosed with mucin producing tumors, pancreatic cystic tumors, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (18)

Erasme University

Brussels, Belgium

Location

Universite Chatolique Louvain

Brussels, Belgium

Location

Gentofte University Hospital

Copenhagen, Denmark

Location

University Hospital

Odense, Denmark

Location

Institute Paoli Calmettes

Marseille, France

Location

Caritas-Krankenhaus

Bad Mergentheim, Germany

Location

St. Josef Hospital

Bochum, Germany

Location

SRH Klinik

Gera, Germany

Location

University Clinic Mainz

Mainz, Germany

Location

Dr.Horst-Schmidt-Klinik

Wiesbaden, Germany

Location

HELIOS Klinikum Wuppertal, University of Witten/Herdecke

Wuppertal, Germany

Location

Hospital San Raffaele

Milan, Italy

Location

Erasme Medisch Centrum

Rotterdam, Netherlands

Location

University of Haukeland

Bergen, Norway

Location

University of Medicine and Pharmacy Craiova

Craiova, Romania

Location

University Hospital Santiago

Santiago, Spain

Location

Glasgow Royal Infirmary

Glasgow, United Kingdom

Location

Newcastle Upon Tyne Hospitals

Newcastle, United Kingdom

Location

Related Publications (9)

  • Frey H. [Realtime elastography. A new ultrasound procedure for the reconstruction of tissue elasticity]. Radiologe. 2003 Oct;43(10):850-5. doi: 10.1007/s00117-003-0943-2. German.

    PMID: 14605701BACKGROUND
  • Ophir J, Alam SK, Garra B, Kallel F, Konofagou E, Krouskop T, Varghese T. Elastography: ultrasonic estimation and imaging of the elastic properties of tissues. Proc Inst Mech Eng H. 1999;213(3):203-33. doi: 10.1243/0954411991534933.

    PMID: 10420776BACKGROUND
  • Itoh A, Ueno E, Tohno E, Kamma H, Takahashi H, Shiina T, Yamakawa M, Matsumura T. Breast disease: clinical application of US elastography for diagnosis. Radiology. 2006 May;239(2):341-50. doi: 10.1148/radiol.2391041676. Epub 2006 Feb 16.

    PMID: 16484352BACKGROUND
  • Miyanaga N, Akaza H, Yamakawa M, Oikawa T, Sekido N, Hinotsu S, Kawai K, Shimazui T, Shiina T. Tissue elasticity imaging for diagnosis of prostate cancer: a preliminary report. Int J Urol. 2006 Dec;13(12):1514-8. doi: 10.1111/j.1442-2042.2006.01612.x.

    PMID: 17118027BACKGROUND
  • Rago T, Santini F, Scutari M, Pinchera A, Vitti P. Elastography: new developments in ultrasound for predicting malignancy in thyroid nodules. J Clin Endocrinol Metab. 2007 Aug;92(8):2917-22. doi: 10.1210/jc.2007-0641. Epub 2007 May 29.

    PMID: 17535993BACKGROUND
  • Janssen J, Schlorer E, Greiner L. EUS elastography of the pancreas: feasibility and pattern description of the normal pancreas, chronic pancreatitis, and focal pancreatic lesions. Gastrointest Endosc. 2007 Jun;65(7):971-8. doi: 10.1016/j.gie.2006.12.057.

    PMID: 17531630BACKGROUND
  • Saftoiu A, Vilmann P, Ciurea T, Popescu GL, Iordache A, Hassan H, Gorunescu F, Iordache S. Dynamic analysis of EUS used for the differentiation of benign and malignant lymph nodes. Gastrointest Endosc. 2007 Aug;66(2):291-300. doi: 10.1016/j.gie.2006.12.039.

    PMID: 17643702BACKGROUND
  • Saftoiu A, Vilmann P, Gorunescu F, Janssen J, Hocke M, Larsen M, Iglesias-Garcia J, Arcidiacono P, Will U, Giovannini M, Dietrich CF, Havre R, Gheorghe C, McKay C, Gheonea DI, Ciurea T; European EUS Elastography Multicentric Study Group. Efficacy of an artificial neural network-based approach to endoscopic ultrasound elastography in diagnosis of focal pancreatic masses. Clin Gastroenterol Hepatol. 2012 Jan;10(1):84-90.e1. doi: 10.1016/j.cgh.2011.09.014. Epub 2011 Oct 1.

  • Saftoiu A, Vilmann P, Gorunescu F, Janssen J, Hocke M, Larsen M, Iglesias-Garcia J, Arcidiacono P, Will U, Giovannini M, Dietrich C, Havre R, Gheorghe C, McKay C, Gheonea DI, Ciurea T; European EUS Elastography Multicentric Study Group. Accuracy of endoscopic ultrasound elastography used for differential diagnosis of focal pancreatic masses: a multicenter study. Endoscopy. 2011 Jul;43(7):596-603. doi: 10.1055/s-0030-1256314. Epub 2011 Mar 24.

Related Links

Biospecimen

Retention: SAMPLES WITHOUT DNA

Pathology samples obtained from duodeno-pancreatectomies or caudal pancreatectomies done with curative intent, as well as microhistological fragments obtained through EUS-FNA biopsy processed by paraffin embedding

MeSH Terms

Conditions

Pancreatitis, Chronic

Condition Hierarchy (Ancestors)

PancreatitisPancreatic DiseasesDigestive System DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Adrian Saftoiu, Professor

    University of Medicine and Pharmacy Craiova, Romania

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 25, 2009

First Posted

May 27, 2009

Study Start

June 1, 2008

Primary Completion

November 1, 2009

Study Completion

December 1, 2009

Last Updated

January 12, 2010

Record last verified: 2010-01

Locations